Literature DB >> 23967

Actions of angiotensin on adrenergic nerve endings.

B G Zimmerman.   

Abstract

In the perfused vascular bed, vasoconstrictor responses to adrenergic nerve stimulation are augmented to a greater degree by angiotensin II than are the responses to injected norepinephrine. Overflow of adrenergic transmitter is also greater during nerve stimulation in the presence of angiotensin than in its absence. The evidence indicates that facilitation of adrenergic transmitter release rather than uptake blockade accounts for these results. In addition, an increased responsiveness of isolated arterial strips to norepinephrine as well as other agonists appears to contribute to the adrenergic potentiating effect of angiotensin II as well as angiotensin III. This action, which appears to be a cell membrane effect, seems to participate in adrenergic potentiation mainly in the arterial segment of the intact vascular bed. Both of these effects of angiotensin, i.e., facilitation of release and increased smooth muscle responsiveness, appear to be mediated by angiotensin receptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 23967

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  32 in total

Review 1.  Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  Christine R Culy; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Multiple control of inflammation by glucocorticoids.

Authors:  M Di Rosa; A Calignano; R Carnuccio; A Ialenti; L Sautebin
Journal:  Agents Actions       Date:  1986-01

3.  The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline.

Authors:  G B Kondowe; S Copeland; A P Passmore; W J Leahey; G D Johnston
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.

Authors:  J Pernow; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

Review 5.  The renin-angiotensin system in the control of systemic arterial pressure.

Authors:  A B Ribeiro; O Kohlmann; M A Saragoça; O Marson; O L Ramos
Journal:  Drugs       Date:  1985       Impact factor: 9.546

6.  Modulation of neural noradrenaline and ATP release by angiotensin II and prostaglandin E2 in guinea-pig vas deferens.

Authors:  B Driessen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

7.  Angiotensin II-noradrenergic interactions in renovascular hypertensive rats.

Authors:  J B Zimmerman; D Robertson; E K Jackson
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

8.  Angiotensin II: a potent regulator of acidification in the rat early proximal convoluted tubule.

Authors:  F Y Liu; M G Cogan
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

9.  Facilitating interaction between rauwolscine and angiotensin in the mesenteric artery of the rabbit.

Authors:  I Lues; R Vinke; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

10.  A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig.

Authors:  M Rechtman; H Majewski
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.